homonucleosid
analogu
isoxazolidin
framework
synthes
via
cycloaddit
nucleobasederiv
nitron
methyl
acryl
hydrogenolysi
isoxazolidin
contain
thymin
dihydrouracil
theophyllin
adenin
moieti
effici
led
format
respect
analogu
analogu
fragment
synthes
treatment
uracilcontain
nb
nc
isoxazolidin
analogu
homonucleosid
obtain
herein
evalu
activ
broad
rang
dna
rna
virus
none
compound
test
exhibit
antivir
cytotox
activ
concentr
cytostat
activ
compound
toward
nine
cancer
cell
line
test
clura
theo
appear
activ
toward
pancreat
adenocarcinoma
cell
show
ic
valu
respect
isoxazolidin
clura
inhibit
prolifer
colorect
carcinoma
nucleosid
analogu
belong
group
import
antivir
antitumor
drug
howev
resist
drug
toxic
consid
major
factor
limit
effect
therapi
structur
modif
avail
drug
class
nucleosid
analogu
includ
sugar
andor
nucleobas
residu
result
discoveri
varieti
therapeuticallyus
antivir
eg
azidothymidin
azt
carbovir
lobucavir
dioxolan
lamivudin
anticanc
eg
cladribin
gemcitabin
azacitidin
cytarabin
clofarabin
agent
figur
hand
introduct
methylen
bridg
nucleobas
sugar
partli
led
format
homonucleosid
known
resist
hydrolyt
enzymat
cleavag
well
rotat
freedom
compar
natur
nucleosid
furthermor
shown
homonucleosid
substrat
cellular
kinas
abl
pair
nucleosid
watsoncrick
interact
without
appreci
modif
structur
dna
rna
molecul
homonucleosid
contain
adenin
guanin
found
activ
herp
simplex
viru
minimum
inhibitori
concentr
mic
vaccinia
viru
compound
ic
show
activ
influenza
type
viru
figur
homonucleosid
analogu
deoxyuridin
hand
introduct
methylen
bridg
nucleobas
sugar
partli
led
format
homonucleosid
known
resist
hydrolyt
enzymat
cleavag
well
rotat
freedom
compar
natur
nucleosid
furthermor
shown
homonucleosid
substrat
cellular
kinas
abl
pair
nucleosid
watsoncrick
interact
without
appreci
modif
structur
dna
rna
molecul
contain
adenin
guanin
found
activ
herp
simplex
viru
minimum
inhibitori
concentr
mic
vaccinia
viru
compound
show
activ
influenza
type
viru
figur
homonucleosid
analogu
describ
select
inhibitor
viral
uracildna
glycosylas
udg
exert
small
effect
human
enzym
incorpor
isoxazolidin
ring
nucleosid
framework
sugar
part
replac
first
propos
tronchet
cowork
intent
studi
antivir
antibacteri
antifung
activ
compound
research
group
intens
explor
field
thu
compound
phosphonyl
deriv
inhibit
revers
transcriptas
activ
avian
moloney
viru
amv
human
immunodefici
viru
hiv
level
compar
tenofovir
nm
higher
azt
nm
moreov
cytotox
significantli
lower
cytotox
concentr
comparison
azt
figur
order
obtain
compound
suffici
stabil
hydrolyt
enzymat
cleavag
analogu
figur
also
synthes
hand
introduct
methylen
bridg
nucleobas
sugar
partli
led
format
homonucleosid
known
resist
hydrolyt
enzymat
cleavag
well
rotat
freedom
compar
natur
nucleosid
furthermor
shown
homonucleosid
substrat
cellular
kinas
abl
pair
nucleosid
watsoncrick
interact
without
appreci
modif
structur
dna
rna
molecul
contain
adenin
guanin
found
activ
herp
simplex
viru
minimum
inhibitori
concentr
mic
vaccinia
viru
compound
show
activ
influenza
type
viru
figur
homonucleosid
analogu
describ
select
inhibitor
viral
uracildna
glycosylas
udg
exert
small
effect
human
enzym
incorpor
isoxazolidin
ring
nucleosid
framework
sugar
part
replac
first
propos
tronchet
cowork
intent
studi
antivir
antibacteri
antifung
activ
compound
research
group
intens
explor
field
thu
compound
phosphonyl
deriv
inhibit
revers
transcriptas
activ
avian
moloney
viru
amv
human
immunodefici
viru
hiv
level
compar
tenofovir
nm
higher
azt
nm
moreov
cytotox
significantli
lower
cytotox
concentr
comparison
azt
figur
order
obtain
compound
suffici
stabil
hydrolyt
enzymat
cleavag
analogu
figur
also
synthes
incorpor
isoxazolidin
ring
nucleosid
framework
sugar
part
replac
first
propos
tronchet
cowork
intent
studi
antivir
antibacteri
antifung
activ
compound
research
group
intens
explor
field
thu
compound
phosphonyl
deriv
inhibit
revers
transcriptas
activ
avian
moloney
viru
amv
human
immunodefici
viru
hiv
level
compar
tenofovir
nm
higher
azt
nm
moreov
cytotox
significantli
lower
cytotox
concentr
cc
comparison
azt
cc
figur
order
obtain
compound
suffici
stabil
hydrolyt
enzymat
cleavag
analogu
homonucleosid
figur
also
synthes
isoxazolidin
nucleosidenucleotid
analogu
describ
far
nucleobas
attach
therefor
cycloaddit
nitron
nvinyl
nallyl
nucleobas
found
conveni
method
prepar
recent
design
isoxazolidin
analogu
homonucleo
ide
figur
nucleobas
attach
underscor
fundament
differ
alreadydescrib
one
synthesi
homonucleosid
cycloaddit
also
employ
case
nucleobasederiv
nitron
select
alken
appli
sinc
signific
activ
compound
toward
virus
test
notic
wonder
whether
replac
isoxazolidin
moieti
ring
would
lead
improv
antivir
properti
newlydesign
compound
idea
incorpor
moieti
support
presenc
subunit
mani
natur
product
figur
show
antivir
cytotox
antiinflammatori
antimicrobi
properti
among
other
reason
assumpt
homonucleosid
analogu
scheme
moieti
could
possess
interest
biolog
properti
antivir
cytotox
justifi
isoxazolidin
nucleosidenucleotid
analogu
describ
far
nucleobas
attach
therefor
cycloaddit
nitron
nvinyl
nallyl
nucleobas
found
conveni
method
prepar
recent
design
isoxazolidin
analogu
ide
figur
nucleobas
attach
underscor
fundament
differ
alreadydescrib
one
synthesi
homonucleosid
cycloaddit
also
employ
case
nucleobasederiv
nitron
select
alken
appli
sinc
signific
activ
compound
toward
virus
test
notic
wonder
whether
replac
isoxazolidin
moieti
ring
would
lead
improv
antivir
properti
newlydesign
compound
idea
incorpor
moieti
support
presenc
subunit
mani
natur
product
figur
show
antivir
cytotox
antiinflammatori
antimicrobi
properti
among
other
reason
assumpt
homonucleosid
analogu
scheme
moieti
could
possess
interest
biolog
properti
antivir
cytotox
justifi
synthet
strategi
homonucleosid
reli
cycloaddit
nucleobasederiv
nitron
methyl
acryl
follow
hydrogenolysi
synthet
strategi
homonucleosid
reli
cycloaddit
nucleobasederiv
nitron
methyl
acryl
follow
hydrogenolysi
bond
isoxazolidin
scaffold
accompani
intramolecular
cycliz
transform
cycloadduct
compound
scheme
nucleobasederiv
nitron
synthes
n
nucleobas
nmethylhydroxylamin
describ
previous
cycloaddit
nucleobasederiv
nitron
methyl
acryl
carri
methanol
h
scheme
tabl
afford
mixtur
diastereoisomer
isoxazolidin
cistran
ratio
isoxazolidin
calcul
hnmr
spectra
crude
reaction
mixtur
comparison
diagnost
reson
proton
isoxazolidin
ring
well
signal
respect
proton
nucleobas
moieti
case
differ
reson
proton
diastereoisomer
isoxazolidin
also
diagnost
crude
reaction
mixtur
diastereoisom
subject
column
chromatographi
howev
pure
isomer
isoxazolidin
isol
tabl
entri
case
respect
fraction
enrich
isom
scheme
retrosynthesi
analogu
homonucleosid
synthet
strategi
homonucleosid
reli
cycloaddit
nucleobasederiv
nitron
methyl
acryl
follow
hydrogenolysi
bond
isoxazolidin
scaffold
accompani
intramolecular
cycliz
transform
cycloadduct
compound
scheme
nucleobasederiv
nitron
synthes
n
nucleobas
nmethylhydroxylamin
describ
previous
cycloaddit
nucleobasederiv
nitron
methyl
acryl
carri
c
methanol
h
scheme
tabl
afford
mixtur
diastereoisomer
isoxazolidin
cistran
ratio
isoxazolidin
calcul
hnmr
spectra
crude
reaction
mixtur
comparison
diagnost
reson
h
proton
isoxazolidin
ring
well
signal
respect
proton
nucleobas
moieti
case
differ
reson
ch
n
proton
diastereoisomer
isoxazolidin
also
diagnost
crude
reaction
mixtur
diastereoisom
subject
column
chromatographi
howev
pure
isomer
isoxazolidin
isol
tabl
entri
case
respect
fraction
enrich
isom
collect
subsequ
separ
diastereoisomer
mixtur
isoxazolidin
hplc
column
allow
us
obtain
pure
isom
tabl
entri
bh
amount
howev
small
suffici
perform
full
character
newlysynthes
compound
biolog
screen
unfortun
attempt
separ
diastereoisomer
isoxazolidin
appear
fruitless
even
hplc
collect
subsequ
separ
diastereoisomer
mixtur
isoxazolidin
hplc
column
allow
us
obtain
pure
isom
tabl
entri
bh
amount
howev
small
suffici
perform
full
character
newlysynthes
compound
biolog
screen
unfortun
attempt
separ
diastereoisomer
isoxazolidin
appear
fruitless
even
hplc
rel
configur
isoxazolidin
alreadi
establish
recent
describ
isoxazolidin
reduc
sodium
borohydrid
ethanol
known
isoxazolidin
scheme
transform
structur
isoxazolidin
skeleton
remain
unchang
rel
configur
isoxazolidin
alreadi
establish
recent
describ
isoxazolidin
reduc
sodium
borohydrid
ethanol
known
isoxazolidin
scheme
rel
configur
isoxazolidin
alreadi
establish
recent
describ
isoxazolidin
reduc
rel
configur
isoxazolidin
alreadi
establish
recent
describ
isoxazolidin
reduc
sodium
borohydrid
ethanol
known
isoxazolidin
scheme
transform
structur
isoxazolidin
skeleton
remain
unchang
therefor
rel
configur
isoxazolidin
unambigu
establish
consequ
isomer
isoxazolidin
identifi
sinc
similar
spectral
pattern
respect
isoxazolidin
proton
observ
seri
compar
observ
cycloadduct
configur
analog
assign
rel
configur
isoxazolidin
alreadi
establish
recent
describ
isoxazolidin
reduc
sodium
borohydrid
ethanol
known
isoxazolidin
scheme
transform
structur
isoxazolidin
skeleton
remain
unchang
therefor
rel
configur
isoxazolidin
unambigu
establish
consequ
isomer
isoxazolidin
identifi
sinc
similar
spectral
pattern
respect
isoxazolidin
proton
observ
seri
compar
observ
cycloadduct
configur
analog
assign
figur
structur
surprisingli
prefer
conform
dihydrouacilcontain
isoxazolidin
could
assign
set
coupl
indic
exist
conform
equilibrium
isoxazolidin
ring
figur
structur
surprisingli
prefer
conform
dihydrouacilcontain
isoxazolidin
could
assign
set
coupl
indic
exist
conform
equilibrium
isoxazolidin
ring
either
ci
tran
isoxazolidin
contain
uracil
substitut
uracil
residu
also
notic
diastereotop
hydrogen
atom
unit
reson
lower
field
ppm
show
significantli
smaller
vicin
coupl
constant
hz
associ
higher
field
signal
ppm
valu
hz
observ
one
may
conclud
highfield
hydrogen
antiperiplanar
lowfield
one
orient
gauch
depict
newman
project
figur
although
real
reason
restrict
rotat
around
bond
remain
obscur
us
moment
may
simpli
reflect
repuls
interact
steric
bulki
group
men
fragment
final
attempt
transform
isoxazolidin
cycloadduct
deriv
made
follow
procedur
appli
previous
transform
either
ci
tran
isoxazolidin
contain
uracil
substitut
uracil
residu
also
notic
diastereotop
hydrogen
atom
ch
base
unit
reson
lower
field
ppm
show
significantli
smaller
vicin
coupl
constant
hz
associ
higher
field
signal
ppm
valu
hz
observ
one
may
conclud
highfield
hydrogen
antiperiplanar
lowfield
one
orient
gauch
depict
newman
project
figur
although
real
reason
restrict
rotat
around
base
bond
remain
obscur
us
moment
may
simpli
reflect
repuls
interact
steric
bulki
ch
base
group
men
fragment
final
attempt
transform
isoxazolidin
cycloadduct
deriv
made
follow
procedur
appli
previous
transform
expect
sinc
hydrogen
bond
isoxazolidin
scaffold
releas
amino
group
subsequ
intramolecular
cycliz
occur
spontan
scheme
consequ
isoxazolidin
would
provid
isoxazolidin
substrat
synthesi
cisconfigur
mind
conclud
pure
diastereoisom
use
synthesi
mixtur
respect
isom
although
significantli
enrich
one
diastereoisom
maintain
control
stereochemistri
product
form
either
ci
tran
isoxazolidin
contain
uracil
substitut
uracil
residu
also
notic
diastereotop
hydrogen
atom
unit
reson
lower
field
ppm
show
significantli
smaller
vicin
coupl
constant
hz
associ
higher
field
signal
ppm
valu
hz
observ
one
may
conclud
highfield
hydrogen
antiperiplanar
lowfield
one
orient
gauch
depict
newman
project
figur
although
real
reason
restrict
rotat
around
bond
remain
obscur
us
moment
may
simpli
reflect
repuls
interact
steric
bulki
group
men
fragment
final
attempt
transform
isoxazolidin
cycloadduct
deriv
made
follow
procedur
appli
previous
transform
expect
sinc
hydrogen
bond
isoxazolidin
scaffold
releas
amino
group
subsequ
intramolecular
cycliz
occur
spontan
scheme
consequ
isoxazolidin
would
provid
isoxazolidin
substrat
synthesi
cisconfigur
mind
conclud
pure
diastereoisom
use
synthesi
mixtur
respect
isom
although
significantli
enrich
one
diastereoisom
maintain
control
stereochemistri
product
form
recent
report
hydrogen
uracilcontain
isoxazolidin
homonucleosid
b
ura
proceed
smoothli
intramolecular
cycliz
intermediari
ester
accompani
hydrogen
uracil
residu
produc
lactam
b
dihura
good
yield
instead
expect
compound
b
ura
tabl
entri
similarli
b
dihura
obtain
b
ura
recent
report
hydrogen
uracilcontain
isoxazolidin
homonucleosid
b
ura
proceed
smoothli
intramolecular
cycliz
intermediari
ester
accompani
hydrogen
uracil
residu
produc
lactam
b
dihura
good
yield
instead
expect
compound
b
ura
tabl
entri
similarli
b
dihura
obtain
b
ura
hand
mixtur
thyminecontain
isoxazolidin
b
thi
subject
hydrogen
respect
mixtur
b
thi
obtain
mixtur
pure
diastereoisom
isol
column
chromatographi
follow
hplc
tabl
entri
b
hydrogen
uracil
deriv
b
xura
face
problem
case
uracil
deriv
moreov
halogen
atom
remov
nucleobas
skeleton
exampl
hydrogen
mixtur
isoxazolidin
b
brura
led
format
insepar
mixtur
tabl
entri
analog
mixtur
obtain
mixtur
isoxazolidin
b
clura
tabl
entri
e
similarli
hydrogen
b
fura
gave
dihydrouracilcontain
b
dihura
tabl
entri
c
furthermor
respect
mixtur
isoxazolidin
success
hydrogen
provid
contain
dihydrouracil
theophyllin
adenin
nucleobas
tabl
entri
gi
supplement
librari
design
homonucleosid
analogu
bromin
chlorin
atom
halogen
uracil
deriv
propos
treatment
abovement
tabl
entri
insepar
mixtur
nbromosuccinimid
nb
led
format
mixtur
togeth
unreact
scheme
purif
mixtur
silica
gel
column
follow
hplc
allow
us
isol
yield
respect
similarli
reaction
analog
mixtur
nchlorosuccinimid
nc
gave
respect
mixtur
compound
obtain
yield
respect
scheme
isoxazolidin
obtain
evalu
activ
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
human
embryon
lung
hel
cell
cultur
herp
simplex
ko
strain
herp
simplex
g
strain
vaccinia
viru
thymidin
kinas
defici
acyclovirresist
herp
simplex
tk
ko
acv
r
human
coronaviru
strain
cytomegaloviru
davi
strain
varicellazost
viru
tk
vzv
tk
vzv
strain
b
hela
cell
cultur
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
c
vero
cell
cultur
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
yellow
fever
viru
mdck
cell
cultur
influenza
viru
subtyp
influenza
b
viru
ganciclovir
cidofovir
acyclovir
brivudin
zalcitabin
zanamivir
alovudin
mycophenol
acid
amantadin
rimantadin
ribavirin
dextran
sulfat
molecular
weight
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopath
virus
cytotox
compound
test
toward
uninfect
host
cell
defin
minimum
cytotox
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
cytotox
concentr
cc
caus
decreas
cell
viabil
determin
use
colorimetr
mt
assay
system
none
test
compound
show
appreci
antivir
activ
toward
test
dna
rna
virus
concentr
time
none
affect
cell
morpholog
use
uninfect
host
cell
ganciclovir
cidofovir
acyclovir
brivudin
zalcitabin
zanamivir
alovudin
mycophenol
acid
amantadin
rimantadin
ribavirin
dextran
sulfat
molecular
weight
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopath
virus
cytotox
compound
scheme
synthesi
x
br
x
cl
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
isol
isoxazolidin
toward
nine
cancer
cell
line
pancreat
adenocarcinoma
chronic
myeloid
leukemia
colorect
carcinoma
lung
carcinoma
acut
lymphoblast
leukemia
acut
myeloid
leukemia
chronic
myeloid
leukemia
multipl
myeloma
nonhodgkin
lymphoma
normal
retina
noncancer
cell
htert
docetaxel
etoposid
stauroporin
use
refer
compound
compound
test
toxic
noncancer
retina
cell
htert
concentr
also
activ
cancer
cell
isoxazolidin
test
except
b
fura
exhibit
moder
activ
pancreat
adenocarcinoma
cell
ic
among
clura
theo
activ
ic
valu
respect
tabl
case
cisconfigur
isoxazolidin
cisconfigur
slightli
less
activ
compar
respect
transisom
eg
versu
versu
versu
vs
howev
correl
appli
uracil
dihydrouracil
theophilinederiv
moreov
sever
isoxazolidin
inhibit
prolifer
ic
ic
cell
ic
tabl
solut
nitron
mmol
methanol
ml
methyl
acryl
ml
ad
mixtur
stir
c
h
solvent
remov
vacuo
crude
product
purifi
silica
gel
column
use
chloroformmethanol
vv
eluent
respect
fraction
subject
hplc
x
bridg
prep
obd
mm
column
use
watermethanol
vv
afford
pure
isoxazolidin
solut
respect
isoxazolidin
mmol
methanol
ml
stir
atmospher
pressur
hydrogen
pdc
mmol
pd
oh
c
mmol
room
temperatur
day
suspens
filter
layer
celit
solvent
remov
vacuo
crude
product
chromatograph
silica
gel
column
chloroform
methanol
mixtur
vv
hplc
use
x
bridg
prep
obd
mm
column
water
methanol
mixtur
vv
eluent
give
dd
j
hch
j
hz
hchclura
ch
n
ddd
j
hz
j
hz
j
hz
h
ddd
j
hz
j
hz
j
hz
h
compound
evalu
differ
herpesvirus
includ
herp
simplex
viru
type
strain
ko
thymidin
kinasedefici
tk
ko
strain
resist
acv
acv
r
herp
simplex
viru
type
strain
g
adeno
human
coronaviru
varicellazost
viru
vzv
tk
strain
oka
tk
vzv
strain
human
cytomegaloviru
hcmv
strain
davi
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
respiratori
syncyti
viru
rsv
vesicular
stomat
viru
yellow
fever
viru
influenza
viru
subtyp
influenza
b
viru
antivir
assay
base
inhibit
virusinduc
cytopath
plaqu
format
vzv
human
embryon
lung
hel
fibroblast
african
green
monkey
kidney
cell
vero
human
epitheli
cervix
carcinoma
cell
hela
madin
darbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
vzv
cell
cultur
incub
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
vzv
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopath
viral
plaqu
format
cytotox
test
compound
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
assay
perform
microtit
plate
well
ad
tumor
cell
given
amount
test
compound
cell
allow
prolifer
c
humidifi
co
control
atmospher
end
incub
period
cell
count
coulter
counter
ic
inhibitori
concentr
defin
concentr
compound
inhibit
cell
prolifer
seri
isoxazolidin
analogu
homonucleosid
synthes
cycloaddit
nucleobasederiv
nitron
methyl
acryl
base
hnmr
vicin
coupl
constant
prefer
e
conform
establish
isoxazolidin
ring
hydrogenolyt
transform
isoxazolidin
perform
produc
respect
contain
thymin
dihydrouracil
theophyllin
adenin
nucleobas
applic
establish
protocol
sinc
hydrogen
uracilcontain
isoxazolidin
homonucleosid
halogen
atom
remov
nucleobas
skeleton
deriv
brura
clura
obtain
via
treatment
uracilcontain
nb
nc
respect
obtain
isoxazolidin
homonucleosid
evalu
broadspectrum
dna
rna
virus
appear
inact
concentr
antiprolif
properti
obtain
isoxazolidin
evalu
nine
cancer
cell
line
sever
exhibit
moder
inhibitori
activ
time
inact
toward
normal
retina
cell
